Ben Stevens
Ben is the editor of Business of Cannabis. Since 2021, he has researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.
Ben Stevens · page 23
- Legal Analysis
How Has the UK Government’s Position on Cannabis Changed Under Labour?
The UK’s cannabis industry, one of the largest on the planet, sits at a crossroads.
- Industry Trends
“A Brick Wall for Every Patient”: GOP Bill Threatens Medical Cannabis Protections, Blocking Rescheduling in the Process
US Republicans have sharpened their sights on cannabis rescheduling, advancing legislation that would not only stop any hope of rescheduling in its tracks, but also potentially remove existing protections for medical cannabis dispensaries across the US.
- Legal Analysis
£13.3 Billion Boost: Medical Cannabis Expansion Touted as Solution to NHS Woes
Expanding NHS access to medical cannabis could add £13.3bn to the UK economy over 10 years, easing NHS costs and reducing long-term sickness.
- M&A Activity
Barney’s Farm Terminates Landmark Merger With Sensi Seeds & Ilgm Amid Accusations of Failed Payments
Dutch seed bank Barney’s Farm, one of the leading names in the global consumer cannabis seeds market, has backed out of a landmark merger with Sensi Seeds and US firm I Love Growing Marijuana (ILGM).
- Events
UNESCO’s Mondiacult to Spotlight Cannabis in Global Cultural Policy for First Time
For the first time in its history, UNESCO’s flagship cultural policy conference will give cannabis a prominent platform, marking the centenary of its international prohibition and reflecting its growing cultural acceptance.
- Legal Analysis
Switzerland Plans for a Single Online Cannabis Retailer: What Will This Mean for its Upcoming Adult-Use Market?
Switzerland’s draft cannabis plan proposes a single online retailer, raising opportunities and risks as it pursues Europe’s first adult-use market.
- Cultivation
Germany as Europe’s Beacon: How Enua Is Securing Medical Cannabis Amid Legalization Shifts
In the latest instalment of our series spotlighting the expert contributors to Prohibition Partners’ newly launched Insights Hub, we sat down with Enua to dicsuss the risks posed by Germany’s drift towards adult-use in its medical market, the company’s proposals for strengthening pharmacy-led distribution and introducing over-the-counter cannabis products, and its long-term mission to ensure…
- Press releases
Releaf Prepares to Launch Its ‘Technology-Led’ Medical Cannabis Model Internationally
Releaf, a leading UK medical cannabis clinic, has announced the launch of a new global expansion strategy as it prepares to take its proven healthcare model to new international markets.
- UK & Europe
Inside Switzerland’s Cannabis Legalisation Plans
Switzerland has now launched its three-month public consultation on its ambitious proposals to launch a fully regulated adult-use cannabis market, taking a decisive step towards becoming the first European country to do so.
- Uncategorized
Business of Cannabis Returns to New York for Exclusive 2025 VIP Summit
The Business of Cannabis: New York Summit returns to Williamsburg on Wednesday, November 6, bringing together 300 of the most influential figures shaping the future of cannabis in New York, and across the United States.
- Companies
Curaleaf Launches UK’s First CE-Certified Liquid Medical Cannabis Inhaler
Curaleaf Laboratories has announced the launch of the UK’s first CE-certified liquid medical cannabis inhaler, aiming to address growing patient and clinical demand for a discreet and reliable inhalation method.
- CBD Market
Thousands of CBD Products Take Final Step Towards UK Novel Foods Approval
The UK’s long-running project to regulate CBD (cannabidiol) products has taken another major step forward, seeing thousands of products make it to the final phase of the novel foods approval process.
